Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers

NCT02404805 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

HIV
Hepatitis C

Interventions

DRUG: dolutegravir
DRUG: simeprevir

Sponsor

University of Colorado, Denver